Here comes your lead
General info
Who can participate in ‘Here comes your lead’?
Biocat is looking for projects of excellence in the early-stages of drug discovery in therapeutics that are interested in bringing these therapeutics into the next stages of development.
How does ‘Here comes your lead’ work?
Biocat compiles the projects, with non-confidential information, and facilitates direct contact with the partners (national and international platforms, CROs and big pharma), which will review the proposals and choose the ones that best fit their needs and interests to schedule a private meeting.
Speakers
Thomas
Hanke
EVP Head of Academic Partnerships
Evotec
Austin
Smith
VP Clinical Development
LINK Medical Research
Xavier
Codony Soler
Open Innovation Partnership & Consortia
Welab Barcelona
Martí
Monras
Key Account Manager, Chemical & Pharma Area
APPLUS
Bebiana
Sá Moura
Head of Discovery at VectorB2B
VectorB2B
Carlo
Carolis
Head of Protein Technologies Unit
CRG – Centre for Genomic Regulation
Israel
Ramos
Drug Screening Coordinator
Institute for Research in Biomedicine (IRB Barcelona)
Partners
Do you have an early-stage research project in drug discovery and want to push it into the next steps (target validation, hit to lead or lead optimization)? 'Here Comes Your Lead' can help you to achieve your goal!
Get in touch with national and international platforms and CROs looking for projects to establish a research collaboration model with shared risk and profit.
Program partners: Evotec, LifeArc, Vector B2B, Leads to Development, WeLab, APPLUS Laboratories, Institute for Biomedical Research (IRB) and Centre for Genomic Regulation (CRG).
Meet your partner to accelerate your project in drug discovery!
Send us your project of excellence in the early-stages of drug discovery in therapeutics (e.g. new targets or new hits identified), and that are interested in bringing these therapeutics into the following stages: target validation, hit to lead or lead optimization. From academics or start-ups.
The format of requested applications is a non-confidential onepager document (pdf) that should address at least: tittle, brief description of the asset, potential indications, advantages, stage of development, needs, leaders (scientific, clinical, business, if applicable) and entity. More info can include links to webpages, papers, patents. Language: English.
A model for your inspiration can be found here.
Applications can be submitted exclusively online along with the registration form.
Deadline: 23 August 2021.
Applications to private B2B meetings will be reviewed by our panel of partners, who will select their matches. Notifications about your meeting’s agenda will be sent by the end of September.